Actively Recruiting
Pilot Study of Focal Mass Drug Administration with Dihydroartemisinin Piperaquine to Prevent Malaria in Pregnant Women and Their Households
Led by University of North Carolina, Chapel Hill · Updated on 2026-11-03
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a focal mass drug administration program to protect pregnant women from malaria by treating their household members. This pilot study aims to assess the feasibility, acceptability, and preliminary effectiveness of this approach in rural western Uganda. The hypothesis is that eliminating malaria parasites within the household will add protection for pregnant women, especially when access to care is limited or delayed. Participants will be randomized into three groups one receiving a single dose of Dihydroartemisinin Piperaquine, another receiving monthly doses, and a control group receiving standard care. The medication is taken orally based on weight. The study team will monitor treatment adherence, willingness to take the drug, and adverse events. Pregnant women and their households will be followed through delivery, with several evaluations conducted during pregnancy. Participants will undergo assessments including malaria rapid diagnostic tests and polymerase chain reaction testing to detect infections. Researchers will measure clinical malaria incidence, asymptomatic infections, maternal anemia, and adverse birth outcomes. The study will also track the percentage of household members receiving treatment and adherence over approximately five months. Safety and effectiveness of the drug administration program will be closely monitored throughout the study period.
CONDITIONS
Brief Title
Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy
Research Team
B
Boyce
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here